Sample matching is a fundamental capability that can have high probative value in a forensic context if proper validation studies are performed. In this report we discuss the potential utility of using the elemental composition of two bioagent samples to decide if they were produced in the same batch, or by the same process. Using guidance from the recent NRC study of bullet lead analysis and other sources, we develop a basic likelihood ratio framework for evaluating the evidentiary weight of elemental analysis data for sample matching. We define an objective metric for comparing two samples, and propose a method for constructing an unbiased population of test samples. We illustrate the basic methodology with some existing data on dry Bacillus thuringiensis preparations, and outline a comprehensive plan for experimental validation of this approach.
Introduction
Matching samples of materials found at a crime scene with those associated with a person accused of a crime is a well-established method in forensic science. However, the probative power and admissibility of such evidence in the courtroom is receiving greater scrutiny in recent years due, in part, to the increasingly rigorous interpretation of the Federal Rules of Evidence as represented in the Daubert 1 and Kumho 2 decisions, and partly due to the great success of DNA evidence, which is often cited as an exemplar [3] [4] [5] [6] . The importance of this trend is reflected in the recent NRC study of bullet lead analysis, and the subsequent withdrawal of this method by the FBI [7] [8] [9] . The fundamental scientific basis for the validity of even long-accepted "classical" forensic practices such as fingerprint and hair analysis have been recently questioned 10 . It is important to note that in most of these cases, the actual analytical method used to characterize the samples is not in question. The object of criticism is more often the scientific basis for assigning statistically meaningful inferential power to such data.
In microbial forensics investigations, it is often desirable to determine if an agent used in a crime or act of terrorism can be matched to the agent used in another, similar event, or to material recovered from a laboratory suspected too be the source of the agent 11 . The potential probative value of sample matching in a microbial forensic context can be illustrated by two scenarios:
(1) Envelopes containing B. anthracis powders are received at two or more separate locations, on significantly different dates, and the envelopes themselves do not look similar. A finding that the agent came from a common source greatly increases the odds that the same person or group is responsible for both events.
(2) Material from an envelope is compared with material from a stock found in a suspect source laboratory. A match between the characteristics of the materials clearly increases the probable association between the two anthrax samples.
Genetic sequence information can be used to relate the organism in an agent to organisms found at suspected sources 12 . However, as was evident in the investigation of the Anthrax letters incident of 2001, several laboratories may possess isolates of genetically identical organisms 13 . In some cases the pathogen may be present in common in environmental settings and thus available to many, in principle. If the agent is a toxin such as ricin there may be insufficient residual genetic material to analyze. Thus, there are many reasons why additional means for relating bioagent samples are needed. It is natural to turn to chemical or physical analysis for a solution to this problem. While the courts have already considered pathogen DNA sequence evidence in a microbial forensics context 14 , it has not yet deliberated on the use of chemical and physical evidence in a bioterror or biocriminal trial. However, we can be certain that if such an occasion arises, the scientific support for this kind of evidence will receive rigorous scrutiny with regard to its admissibility and evidential weight. Thus, it is important to build a strong scientific basis for drawing inferences about sample matching when using chemical or physical characteristics of agent materials. Intuitively we expect that:
• The variance among elemental concentrations among samples from a single batch will be smallest, since each agent particle has experienced identical, or nearly identical growth and processing conditions;
• The variance among elemental concentrations from different batches made by the same process and the same materials may be somewhat larger due to uncontrolled random variations in how the process is carried out;
• Variance among elemental concentrations from batches made by the same nominal process but with different sources of starting materials will be larger still, due to variation in the elemental composition of starting materials from different sources; and
• The largest variance in elemental composition is expected among batches made by completely different processes utilizing different materials.
However, experimental studies are required to determine quantitatively and statistically the extent to which these intuitive ideas are correct when one considers a representative variety of growth and production processes. Ultimately, such studies should provide a sound statistical basis for deciding whether it is likely that two samples came from the same batch of material, or were made by different processes. April 21, 2006 Page 5 of 41
While it is clear that chemical or physical characteristics could provide information that pertains to agent preparation, we should be careful not to exaggerate current capabilities in this regard. A recent paper has claimed:
"… elemental signatures … are useful for separating B. subtilis spores based on culture media, and the method may thus be applied to microbial source attribution in the future." 19 In fact, however, the reliability with which this or any other specific information about the growth and preparation procedure can be deduced from chemical and physical analysis remains to be demonstrated. Similarly, the application of such information to "source attribution" will only be possible with considerably more extensive validation than was presented in the cited publication. A careful evaluation of the use of elemental data for sample matching purposes is a critical first step in this direction.
Recent events in a related arena -the NRC analysis of bullet lead examinations and the subsequent discontinuation of this method by the FBI laboratories -provide an example of how careful scientific validation is critical if sample matching evidence is to be admissible and have defensible probative value. A new paradigm for conducting the evaluation and validation of forensic test methods is emerging, based on explicit likelihood analysis 20 . Under this paradigm, the key steps in evaluating and validating the application of elemental analysis to bioagent sample matching are:
Defining the "population" -i.e. the complete set of growth and preparation methods that might be used to generate the bioagent, and all of the potential sources for starting materials used in these processes.
Defining the signature -i.e. choosing the set of elements whose concentrations are to be determined in the method.
Defining an objective metric for decision -i.e. a (scalar) quantity defined in terms of the elemental concentrations that can be used to decide if two samples are related or not.
Characterizing the population -i.e. collecting elemental composition data on a set of bioagent materials generated by representative sampling of growth and preparation methods.
Evaluating the "receiver-operating characteristic (ROC)" -i.e. determining the dependence of the false positive and false negative rates of the method on the value of the chosen metric.
In this report, the term "validation" will refer to a two-phase process. First, the performance of the test is evaluated on a set of samples drawn from a representative population of samples. The test performance is expressed as a ROC curve. In the second phase, the performance is validated by a blind test on a completely independent set of samples drawn from the same population, or from a related population. This April 21, 2006 Page 6 of 41 evaluation/validation paradigm is explicitly adapted from the literature on clinical and medical diagnostics. It should be noted that the definition of the sample "population" is one of the most critical steps in applying the evaluation/validation paradigm to the sample matching problem. It is essential that the sample sets used in this process are chosen in a defensibly unbiased way. This issue occupies a substantial part of the discussion in subsequent sections.
We will begin by outlining a method of analysis based on a standard framework that uses the receiver-operating characteristic (ROC) and likelihood ratios. An analysis of attribution that derives key quantities within this framework is contained in appendix 1. The application of this approach will then be demonstrated using recent data generated at Los Alamos National Laboratory based on samples generated at Lawrence Livermore National Laboratory. It should be emphasized that this analysis is merely presented for illustrating the method, because the data set is severely limited in extent. We then consider in more detail the nature of the "population" of growth and processing methods, and suggest a scheme for obtaining a representative set of samples for a more thorough evaluation and validation of the sample matching analysis method.
A likelihood ratio framework for bioagent sample matching analysis
In this section we describe a simple statistical framework for analyzing elemental data for purposes of drawing conclusions about the relatedness of samples. The terms "process", "batch", "replicate batch", "non-replicate batch" and "replicate sample" are used ubiquitously in this report and have the following definitions:
Process -a recipe following a fixed set of instructions for producing the finished agent. For bacteria and viruses, this includes both growth and post-growth processing. For biological toxins, it includes processes for extraction, purification and any subsequent chemical or physical treatment of the agent. Processes are distinguished by the types and amounts of materials used to make the agent, including growth media, chemical additives, solvents, etc.; and by choices of physical methods such as separation, drying and milling.
Batch -a single volume of material made from a single set of starting materials and following a fixed procedure (i.e. a "process", defined above.) For the case of a bacterial agent, a batch might be material produced from a single bench-top fermentation vessel, a set of shake flasks containing a common growth medium, or a set of agar plates poured from the same volume of prepared growth medium. In the latter two cases, material pooled from a set of shake flasks or agar plates and subsequently processed together would certainly constitute a single batch.
Replicate batches -A set of batches made by the same process where there is intentional duplication of materials and physical process parameters; material differences among replicate batches arise from un-intentional or uncontrolled changes in material quantities or parameters. Page 7 of 41 Non-replicate batches -A set of batches made by a common process, but where one or more factors are the result of independent choices among materials, equipment, or parameters not rigorously defined by the process description. An example would be where a bacterial culture is grown by the same method in two independent laboratories, where each lab obtains its materials from independent sources, or the staff uses slightly different procedures as interpreted from the same description of the process.
Replicate samples -samples drawn at random from a single batch of material, regardless of its homogeneity.
In general, bulk elemental analysis of two bioagent samples could result in one of three possible decisions:
• They were drawn from the same batch of original material. We will refer to this hypothesis as B 0
• They were made by the same process (but possibly non-replicate batches, using starting materials from different sources or different lots, or with slightly different process parameters). We will refer to this hypothesis as P 0 .
• They were drawn from batches made by different processes. This is simply the negation of the same process hypothesis,  P 0 , but also clearly implies  B 0 .
There is also the possibility that the sample was made by pooling different batches, but in general it would be difficult to discern this by bulk analysis alone. Techniques that can analyze single agent particles, such as PIXE or SIMS might be more appropriate, but we will not treat this problem here.
An elemental analysis method like ICP-OES can measure the concentrations of a wide variety of elements down to ppb levels 21 (depending on the element and sample size.) The set of concentrations of those elements (e.g. Na, K, Ca, Sr, Mn, Zn, …) define a characteristic "elemental concentration vector" associated with a sample. The particular set of elements chosen for sample matching analysis must be determined, at least in part, by empirical considerations, such as which elements are highly likely to be above the detection limit for a given sample size for the chosen elemental analysis method. Given the elemental concentration vectors V 1 and V 2 for samples 1 and 2, one can define a distance metric Δ 12 (V 1 , V 2 ) to describe the difference between the elemental signatures of the two samples. There are various ways that Δ 12 can be defined, and we will choose a particular formula in the next section. In any case Δ 12 is the fundamental statistic that is used to decide if two samples are more or less likely to be related.
The premise behind sample matching analysis is that Δ 12 is materially relevant to the question of whether the two samples being compared came from the same source, i.e, from a common laboratory or a common batch of biological agent. In Appendix 1 the Where L 0 is the hypothesis that the two samples originated in the same laboratory, and O(L 0 ) and O(L 0 |Δ 12 ) respectively are the prior and posterior odds that L 0 is true. Thus, the materiality test 22, 23 for the relevance of Δ 12 in court is that LR(Δ 12 ) >1. An explicit analysis relating LR(Δ 12 ) to the hypotheses L 0 , B 0 and P 0 are given in Appendix 1.
The ultimate object of an evaluation/validation study is to show that the test procedure in question provides defensible (and useful) estimates of LR(Δ 12 ). To achieve this, it is necessary to obtain a set of samples that represent an unbiased sampling of a "population" of laboratories, processes, batches, and replicate samples, determine their elemental composition, and empirically determine the distributions of Δ 12 values for the sub-populations of sample pairs that are and are not from the same batch or process. The standard way to summarize this data is the receiver operating characteristic (ROC) curve 24 , which displays the probability of true positive findings against the number of false positives as the test statistic increases or decreases in value. The value of LR can be estimated for any value of Δ 12 from the ROC curve. This approach has been adopted in a number of contexts where critical decision-making is dependent on the results of experimental tests, including clinical testing and medical diagnosis [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] .
Note that in this scheme, legal testimony about the significance of a particular value of Δ 12 never needs to state that there is a "match" between samples. The relevant (and admissible) evidence is that the observed value of Δ 12 increases (or decreases) by a certain amount the likelihood that the samples were drawn from the same batch or made by the same process. Another advantage of the ROC curve approach to characterizing sample matching analysis is that objective criteria then exist for comparing to other tests (using different analysis methods or different definitions of Δ 12 ) that have the same aim.
The sets of test samples used to construct and validate the ROC curve are drawn from a selection of M L laboratories, each independently producing M B replicate batches of agent for each of M P distinct processes, where each batch is divided up into N replicate samples. The structure of the conceptual M L x M P x M B source "population" is discussed in more detail in section 4. We suggest an explicit scheme for an evaluation/validation study involving different laboratories and processes. However, before describing this study, it is useful to apply the ROC analysis to some existing data to illustrate the method and to obtain some useful results to inform the plan.
Application to some existing data
The easiest way to illustrate the procedure outlined in the last section is to explicitly work through some existing data. The data set we shall use is a set of elemental concentrations for a set of Bacillus thuringiensis israelensis (Bti) samples that were grown and processed using a variety of methods. A summary of the preparation methods used for these samples is given in Table 1 . The elemental concentrations were measured by Tom Yoshida at Los Alamos National Laboratory using ICP-OES and presented at the 3 rd quarterly review meeting of the NBFAC National Laboratory R&D program on January 19 th , 2006 36 . For convenience this data is presented in Table 2 .
Several points must be noted about this data set. First, the sample matrix (Table 1) contains only part of the idealized NxM L xM B xM P set of samples discussed above. All of the samples were made in one laboratory. (In the language of Appendix 1, the prior probability of L 0 is unity.) Seven distinct processes are represented. Only one process has more than 1 batch associated with it, and there are no true replicate samples associated with any one batch. The absence of analytical replicates is an unfortunate consequence of limited sample availability. In the absence of a better estimator for variation among replicates we will use the data for acetone and lyophilized samples as if it were a replicate pair. This effectively reduces the number of distinct processes to 4. While this data set is far too small to provide accurate assessment of a ROC curve for the sample-matching test, it is large enough to illustrate the method. Our analysis of this data is based on a pairwise distance estimator Δ 12 defined by
where the sum over l is over the N elements in the fingerprint, and σ l 2 is a statistical weighting factor discussed below. In this expression, normalization of the pairwise difference by the average of the pair helps to control for large changes in absolute concentration from element to element. When C 1l >> C 2l or C 2l >> C 1l , the square of the difference divided by the sum approaches 1. Thus, the maximum value that Δ 12 can attain is
The first issue that needs to be addressed is how to define and estimate the weighting factor σ l 2 . For each element l, σ l 2 is an estimate the variance of the quantity d l defined by:
where i and j stand for independent pairs of data points drawn from the population of concentration values {C il } for that element determined by the replicate measurements on a batch from a particular process. (In the subsequent discussion, we will drop the index p since we will always be concerned with data from one particular process.)
The best way to estimate this variance is by making measurements on a number of replicate samples from one batch each of a set of representative processes. For each element l, this produces a set of concentration values {C pil } that represent the variance April 21, 2006 Page 11 of 41 found in a single batch for each process p. There are two sources for this variation: (1) analytical variation due to instrument noise or uncontrolled random procedural variations, and (2) actual sample variation between replicates from the same batch. These two will typically be convoluted together.
If there is not much variation among the measurements for a particular element, simple linearized error propagation can be used to estimate the variance in d l from the variances in the concentration values for that element.
However, if the variance for an element is apparently large, then a direct estimate must be determined by sampling pairs of concentration values drawn from {C il }.
It should be noted that implicit in this formulation is the assumption that the variations in elemental concentration among replicates is uncorrelated. Thus, a more rigorous treatment would include the possibility of correlation. As part of a more general validation exercise, replicate experimental concentration data should be tested to see if the variations in concentration among the elements are correlated or not.
Since the data set in Table 2 has at most 2 "replicates" each for 4 of the 5 batches, it is not possible to estimate σ l 2 in the prescribed way. Instead, we have simply used the difference between the two "replicate" concentration values divided by their average, and then calculated the root mean square of these values over the 4 batches to generate a σ l 2 value for use in formula (2). The results of these calculations are summarized in Table 3 . Based on the σ l 2 values in Table 3 , the value of Δ max is determined to be 11.8. Table 3 . Values used for estimating σ l 2 . Table 2 . This data is shown in Table 4 .
The data in Table 4 is used to generate a ROC curve for batch-matching in the following manner. For each observed value of Δ, the number of sample pairs that had values less than or equal to Δ and were from the same batch (i.e. for which B 0 was true) is tabulated. Similarly, for each observed value of Δ, the number of sample pairs that had values less than or equal to Δ and were from different batches (i.e. for which B 0 was false) is tabulated. The cumulative numbers of "true positives" and "false positives" thus associated with each Δ are then respectively divided by the total number of true positive pairs (4) and true negative pairs (32) represented in this data set. By this process, each observed value of Δ has associated with it the fraction of true positives and fraction of false positives that would occur if we chose that value of Δ to be the criterion for deciding that the two samples were from the same batch. By plotting the true positive values against the true negative values we generate the ROC curve shown in Figure 2 . The same procedure involving the hypothesis P 0 can be used to generate the ROC curve for process matching, shown in Figure 3 . Table 4 . Also shown for convenience is the value of Δ associated with each pair of true and false positive fractions. . ROC curve for process matching generated from the data in Table 4 . Table 4 that the values of Δ for pairs that came from the same batch are well separated from those that did not. For values of Δ ≤ 0.11 there are no false matches, and all true positives are "detected." This is clearly reflected in the corresponding ROC curve of Figure 2 , which has the characteristic shape of a "perfect" test. Note that there is a relatively large gap between the largest value of Δ associated with B 0 (0.11) and the lowest value of Δ associated with  B 0 (0.29). In a larger, more diverse sample set it seems April 21, 2006 Page 14 of 41 possible that this gap would be much smaller, or perhaps disappear entirely and cause the ROC curve to take a more typical ("imperfect") form.
It is clear from
Note, on the other hand, that the data in Table 4 does not support quite as clear a separation of the Δ values for samples generated by different production methods. The Δ values for (B7,F2) and (B7,G2), which represent pairs that were not made by the same method, are very close to the Δ value for (B1,B3) which were. While Δ ≤ 0.34 provides a clean separation between samples made by the same method, a larger sample population would almost certainly exhibit greater commingling of values for samples made by the same method and values of samples made by similar, but not identical methods. In that case any choice of Δ might result in non-zero values for the false positive and false negative test probabilities.
An unfortunate consequence of a ROC curve for perfect classification is that the likelihood ratio is effectively infinite when Δ is less than the threshold value and zero when Δ is greater than the threshold value. (In general, LR(Δ) is the slope of the ROC curve.) However, the point estimates of true positive and false positive probabilities for a given threshold value of Δ that are generated by the ROC curve are of little utility without estimates of their uncertainty. A number of standard methods exist for estimating this uncertainty at a desired confidence level (usually taken to be 95%) 37, 38 . As an example, in Tables 5 and 6 we have generated estimates of confidence intervals for the conditional probability matrix for Δ ≤ 0.11 and Δ ≤ 0.34 respectively. Tables 5a and 6a give the test results for classification into B 0 and P 0 respectively. Estimators of the false positive and negative rates are nominally zero, but this is clearly not an accurate way to characterize the sensitivity and selectivity of the test, given the small size of the sample set. Therefore, confidence intervals for the conditional probability estimates were generated by using a web-based Bayesian method 39 , and are displayed in Tables 5b and 6b.
In spite of its limited size and diversity, we can draw several conclusions from the dataset analyzed in this section. First of all, it may be possible to obtain a very clean classification of samples into "same batch and "different batch" categories using the measure Δ 12 defined in equation (2). The results are consistent with the intuitive expectation that the false negative rate would be higher than the false positive rate for declaring that two samples come from the same batch. Similarly, intuition also suggests that there would be a higher false positive rate for declaring two samples to have been produced by the same method, because not all methodological variants will affect the elemental composition. However, the small number of samples, limited number of batches and restricted range of processes contained in this data set preclude us from drawing more precise conclusions. Clearly a more extensive validation study is required before this method can be used in a forensic application. In the next section we will propose a plan for such a study. 
# of test results

Positive test results
P(Δ ≤ Δ b | B 0 ) ≥ 0.55 True Positive P(Δ ≤ Δ b | B 0 ) ≤
An experimental design for a sample matching validation study
While the results in section 3 suggest that a useful sample-matching test can be based on the elemental profile of a biological agent sample, the limited nature of the sample set leads to considerable uncertainty about the true ROC curve for such a test. This section discusses a potential method for determining better estimates of test performance. The fundamental idea is to construct a more representative population of agent samples (using a B. anthracis surrogate that is much closer than B. thuringiensis) and to use samples from this population in two distinct phases of testing. In the first phase, a set of samples are generated and analyzed to determine the ROC curve. In the second phase, samples are randomly selected from well-characterized archival materials whose provenance is known, or generated independently from the original set, and blindly evaluated to validate the prior performance estimate.
A. General considerations
Before discussing more particular features of the validation process, it is of great value to review the potential sources of false positive and negative rates in sample matching analysis of biological agents. Clearly, an unbiased design of the validation exercise must provide a fair chance that these causes of error are embodied in the experimental sample set. Table 7 summarizes the potential reasons for errors in matching bioagent samples. Two sources of error included in this list, data errors (i.e. mistakes in calculation or recording of data) and contamination can be controlled if the laboratories that undertake such measurements have strict QA/QC procedures in place. For purposes of this report, we will assume that these types of errors are improbable. In addition, we assume that the cited sources of error are far more significant in practice than any errors that might arise due to intrinsic uncertainty in the measurement of elemental concentrations. As pointed out in section 3, measurement uncertainty is folded in with the variance of elemental concentrations determined from analytical replicates from the same batch of material. Note also that we have included for completeness the theoretical possibility that growing organisms such as bacteria may have mechanisms that control the maximum or minimum concentrations of certain trace elements within the cell. Thus, in an extreme case, the concentrations of elements in an agent powder might be nearly independent of their concentrations in the starting materials. We know of no such case in practice, but it does lead to the precaution that the organism used in the validation experiments be physiologically similar to the threat agent for which it is a surrogate. The remaining errors will be the primary focus of our considerations.
The exercise with the Bti samples suggests some additional points about decision errors in sample matching. From our results in section 3 we anticipate that very few circumstances will make the signatures of two samples coming from different processes as similar as two samples drawn from the same batch. In other words it is not very probable that there will be a fortuitous match between the (multi-element) signatures of two samples grown by very different methods. However, samples made by certain growth medium formulations (e.g. G medium and Modified G medium, which differ only by the addition of glucose) may not be distinguishable, assuming that the medium components they have in common are drawn from the same lot. Certain process differences may not lead to significant differences in the elemental composition of the agent. For example, we know from the Bti samples that certain differences in drying procedure make very small changes in the elemental signatures. Powder grinding is also a potentially neutral step as far as elemental signatures are concerned. It may be necessary to restrict the scope of the test to a set of "distinguishable processes" and place certain variants into indistinguishable classes.
We may also anticipate that there are a fair number of reasons that two batches of agent made by nominally identical processes could give significantly different elemental profiles. Technicians are known to make unintentional alterations in medium preparation such as using poorly approximated mineral salt concentrations. Accidental contamination with extraneous materials could alter the elemental profile of a bio-agent preparation. Also, small unintentional differences in aeration or temperature conditions during growth could affect growth rate or sporulation time, and modify the uptake of trace elements by spores.
Ideally, all of these potential sources of error and unintentional variation should be reflected in the sample set used to determine the ROC curves of sample matching tests.
In practice, of course, it is not possible to predict the base rate for these errors, so it is not even possible to estimate the number of samples that would have to be generated to guarantee that such variation is fairly represented. False positive (Declaring two samples to be drawn from the same batch or made by the same process when they are not.)
• Tight control on the repeatability of medium lot, preparation procedure, and other process parameters
• High uniformity in manufactured, premixed or pre-poured media • Extreme physiological "leveling" of trace element composition in microbe
• Insensitivity of elemental composition to certain process steps, e.g. drying, washing (e.g. samples B7, F2 and G2 from the Bti sample set.)
• Similarity of certain unit processes, e.g. shake flask vs. fermenter.
• Closeness of certain media formulations e.g. among Bacillus media in the same category (see Table xx ).
• Accidental, random identity in trace element composition of two different media
• Moderate physiological "leveling" of trace element composition in microbe False negative (Declaring two samples to be drawn from different batches or made by different processes, when they are not.)
• Inhomogeneity in a single batch + measurement variance.
• Contamination
• Errors in data analysis or data recording
• Variation in elemental composition of starting materials, from source to source
• Variation in sample preparation by the preparer.
B. The bioagent sample "population".
In forensic sample matching problems that involve the comparison of manufactured products like lead bullets, glass, or agricultural commodities, there is a real "background population" of materials, and the major concern is that databases or reference sample collections contain an adequate and up-to-date representation of this population. In contrast, biological agents are not regularly manufactured, and there is an extremely limited real background population of already-made samples 40 . Instead, the "population" is an imaginary construct, consisting of all possible ways that someone might go about making an agent. In section 2 we introduced the idea of a fictitious sample population consisting of M L "laboratories", M P possible processes, M B replicate batches from each process, and N replicate samples drawn from each of the different batches. The problem is how to generate a set of real samples that adequately represents a statistically valid sample of this imaginary space of possibilities. Within this space, not every process is equally likely. Information from a variety of sources indicates that there are a countable number of processes that have been developed for growing and processing pathogens, and only a handful of these are "popular" among microbiologists engaged in biodefense work. Knowledge of these recipes flows to other laboratories through publications and reports, or when personnel move from one laboratory to another. Analysis of existing information indicates that when criminals or terrorists produce bioagents they draw upon existing information for growth and processing ultimately derived from Western open literature sources. Thus, the prior probability of seeing certain recipes is higher than for others. In the following discussion, we will restrict our attention to Bacillus anthracis production, recognizing that different considerations may apply to other microbial agents.
A particular feature of Bacillus growth is that a wide variety of growth media can be used. In addition to refined, commercial media (e.g. peptones, tryptones, glucose) less refined, complex medium formulations (e.g. corn steep liquor, molasses) can be used.
The former are typical of bench-top fermentations in research laboratories, but may also be used at pilot scale in sophisticated industrial-scale state sponsored biological weapons programs, because it makes separation and purification of the agent easier. Complex medium formulations are often used for manufacturing Bacillus thuringiensis (Bt) based insecticides, and could be readily adopted for B. anthracis production, especially in cases where a Bt plant is surreptitiously being used. Table 8 summarizes this space of possibilities. 
Surreptitious conversion of industrial scale processes
It can be argued that the most likely scenario for terrorist or criminal production of B. anthracis involves bench-top methods using commercial refined media that would typically be found in the research laboratories in which the perpetrators received their training, or mentioned in the literature that they can readily access. Therefore, our discussion will focus on this situation.
To better define the population of benchtop scale B.anthracis production methods from which to draw samples for a validation study, we have assembled information from Table  9 contains a summary of this data. The media can be roughly classified into 7 distinct classes according to the major nutrient sources they contain. There were occasionally differences among the exact formulations quoted for some media, which is another potential source of variability in actual medium composition in practice. Furthermore, we have estimated rough measures of how "popular" a given medium is by counting the number of times the use of each medium formulation has been cited by independent laboratories. This was accomplished by searching PubMed for papers referencing "B. anthracis" in conjunction with a number of other terms, such as "vaccine", "sporulation", "expression", and "detection" and choosing the citations with freely available pdf files. These papers were then searched manually for any information on growth media used to culture B. anthracis or near neighbor surrogates including vaccine strains, B. cereus, and B. thuringiensis. Multiple references to a particular growth medium by the same research group were only counted as a single reference 41 . In addition, some general references on growth media and some specialty publications were consulted. The results in Figure 4 are the number of independent references found for each type of growth medium, a total of 78 references being found in this "random" search. Table 9 provides the key to the medium designators used in Figure 4 . A variety of post-growth processes have been used for separating, washing, and drying Bacillus preparations subsequent to culture. In order to assess the "popularity" of each unit process step we surveyed a variety of reports and consulted with a limited number of experts in this area. Table 10 contains rough estimates of the statistical weight associated with various unit process steps derived from our survey. This table is a greatly simplified representation of the process choices that are available. Several more sophisticated methods for separation have been left out because they do not appear to be widely used at the bench-top scale. In addition, certain steps, such as detergent washing, encompass a variety of choices that are not captured here. Similarly, the weights assigned to each step are tendered with a great deal of uncertainty based on the limited sampling we were able to accomplish. Nonetheless, we believe that Table 10 is sufficiently representative to demonstrate the approach, and provides a basis for future refinement of this data.
A crude representation of the prior statistical weight of any given preparation method is simply the product of the weights associated with the choice of growth medium, growth method, separation method, washing and drying steps. This would be accurate if such choices were, in fact, independent. However, in reality end-to-end processes are usually treated as a whole, and thus it could be expected that many choices of individual process steps would be highly correlated. However, in the absence of a better base of April 21, 2006 Page 22 of 41 information, the assumption of independence at least has the virtue of increasing the diversity of the validating sample set. Combining the information in Table 9 with that in Table 10 and ordering the product probability associated with each process from largest to smallest, one can arrive at a list that crudely represents the weighted population of processes for producing B. anthracis powders. In the present case, we have constructed such a list omitting the drying process, since this is known to have a very small affect on elemental composition. In addition, this list was edited to remove some entries that, for certain reasons, would be much less likely than the simple product of probabilities would imply. For example, the medium blood agar (BAgar) is clearly only associated with growth on agar plates, and not with shake flask or fermentor growth. Similarly the use of flocculants to separate spores from spent medium is exclusively used when growth is in liquid culture, not agar plates. With these amendments, the first 30 entries of this list are given in Table 11 . It should be noted that fermentor growth appears only twice in this list as a consequence of its low probability relative to agar plate and shake flask growth.
The full list of processes is provided in an Excel spreadsheet Processes.xls that accompanies this report. This ordered list is a basis for selecting processes to generate samples used to validate the sample matching method. The statistical weight (product of probabilities) of each method is used to change the relative probability of selecting it at random from the entire "population" represented by the list. While the list in Processes.xls may leave out some plausible processes, it can be argued that it covers the most likely methods that would be used to produce B. anthracis preparations and represents a reasonable estimate of their relative likelihood.
We have used the built-in random number generation tool provided by Excel to generate a list of randomly sampled processes. The "Discrete" distribution type was selected, with the product probabilities associated with each process used to weight the selection. Table  12 contains the first 10 randomly selected processes. Page 23 of 41 Table 11 . The 30 "most likely" process choices for Bacillus production. Key: A -Agar plates; S -shake flask; F -Fermentor; C -centrifuge; P -flocculation; N -no detergent; Y-detergent used; 5 -wash 5x with water; 2 -wash 2x with water.
April 21, 2006 Page 24 of 41 
C. Constructing the set of test samples
The connection between sample matching and attribution described in Appendix 1 implies that there are particular "sub-populations" of pairs of test samples that must be included in any validation study. These "sub-populations correspond to hypotheses regarding the possible origin of the sample pairs and are summarized in Table 13 . Table 13 . Partitioning of the test sample space derived from Appendix 1. The union of these two populations represent pairs of samples drawn from batches of material made by different processes A sample set that captures these sub-populations in an unbiased way can be constructed by the following procedure: First, three or more processes are selected at random using April 21, 2006 Page 25 of 41 the weighted "population" of processes described in the previous section. Secondly, three or more independent laboratories are selected to produce batches of material using the selected processes. A partial factorial design that reduces the total number of batches produced, but retains symmetry is shown in Table 14 . Ideally, the laboratories would be selected at random from a larger pool of potential participants. Identical descriptions of the chosen processes are communicated to each lab, but the laboratories are conceived of as autonomous entities making independent choices of vendors and particulars of execution. A conservative bias could be introduced by suggesting to each lab that the similarity of the replicate batches is of high value to the exercise. It is assumed that, faced with the task of producing identical batches, a laboratory worker would plan to purchase sufficiently large lots of medium or numbers of pre-poured agar plates to complete the task when these are commercially available. Finally, it should be noted that the laboratories need not be physically distinct, but could conceivably involve different persons working in a common lab.
From each of the 18 batches, three replicate samples could be drawn for elemental analysis, leading to 54 separate elemental "vectors." This is the basic block of data that underpins the evaluation/validation procedure outlined in the next section. Appendix 2 provides an explicit accounting of the sizes of the various sub-populations of pairwise comparisons generated by this data set.
D. Validating the ROC curve(s)
Appendix 1 demonstrates that there are two different ROC curves that are necessary to characterize the evidentiary power of a batch-matching test. One of these plots involves P(Δ ≤ Δ b |B 0 L 0 ) versus P(Δ ≤ Δ b | B 0  L 0 ) while the other involves P(Δ ≤ Δ b | B 0 L 0 ) versus P(Δ ≤ Δ b | B 0  L 0 ). The data block generated by the procedure outlined above ought to have sufficient size to provide a reasonable representation of each curve. The process of validation then consists of independently generating a set of samples from the same population (in this case the population of bench-top B. anthracis production processes), Page 26 of 41 performing elemental analysis on them, and comparing the ROC curves from that set to the previous curves. In the validation phase, the analyst should be "blinded" with respect to the origin of the samples, and the elemental analysis results should be reported in a coded fashion. The analysis of this data can be done in two ways. The first way is to use the existing ROC curve to make decisions about the validation set based on a chosen threshold value. Then the number of false positives can be compared to the number predicted by the ROC curve. The second way is to construct a ROC curve from the validation data itself, which is the preferred approach if there is sufficient data.
There are several approaches to comparing ROC curves 35, 42 . One method is to fit the curves to a parametric form and then compare the parameter values to see if they are statistically different. Another method involves comparing the area under the ROC curves, which is a measure of the discrimination power of the test. At any value of the cutoff parameter Δ b we can also test to see if the new probabilities are significantly different from the old by using a chi-squared test. In any case, the validation process can be iterated by using the validation set to "update" the ROC curve, and then testing the new curve against a new (independent) data set. The expectation is that the empirical ROC curve would converge on a form that best represents the performance of the test on the target population.
There are several potential ways to generate the set of samples used in the validation phase. One way would be to use existing archival samples that may be available from other laboratories. Another way is to use an independent block design similar to the one described in section 4C, where laboratories and processes are again randomly chosen from the available "population." Alternatively, this can be done by using a series of several smaller block designs, e.g 2x2 versions of the 3x3 scheme in 4C. Ideally, the validation set would be similar in size to the set used to initially evaluate the ROC curves.
Concluding remarks
The intention of this report is to outline an approach to evaluate and validate samplematching tests using elemental analysis as an example. An important feature of the chosen approach is the adoption of a framework that does not involve defining a "match", but relies instead on estimating a likelihood ratio for any value of a defined pairwise comparison metric determined by elemental analysis. This philosophy is consistent with modern concepts of trace evidence analysis and with recommendations emanating from recent National Research Council studies on several forensic science issues.
There are numerous ways that the specific steps described here could be modified and possibly improved. For example. it is important to note that several segments of the larger "population" of B. anthracis production methods were left out of the treatment in this report. It is likely that these population segments would exhibit somewhat different ROC curves due to the increased variability associated with complex medium components and the increased chance for inhomogeneity among samples from large-scale production runs. In addition, even the set of bench-top processes considered here Page 27 of 41 deliberately excludes a number of less likely processes. More extensive polling of both the literature and active research groups might provide a more accurate picture of the "population" of B. anthracis processes. It is also important to emphasize that the production of other agents, such as F. tularensis or Y. pestis, involve different types of growth media and post-growth processes.
It may be possible to construct improved classifiers that work better than Δ 12 as defined above. For example, principal components analysis (PCA 43 ) could be applied to the elemental concentration vectors to produce a variant of Δ 12 . Given vectors of elemental concentrations on a reference set of agent samples prepared by a variety of methods, the first principle component is a linear combination of the concentrations of the elements that exhibits the most variation over the set of samples. Let C 1n and C 1m be the first principle components of the concentration data for two samples n and m. A metric for judging how similar the two samples are is:
By determining Δ mn for pairs of samples from the same batch, replicate batches, nonreplicate batches and from different processes, it should be possible to select a decision criterion (i.e. Δ mn ≤ Δ 0 ) for declaring that two samples are drawn from the same batch or were produced by different methods. Since this procedure uses the multi-element signature that shows maximum variation over the "population" of samples, the decision criteria so determined are conservative quantities.
Principle component analysis can also be used to decide if certain subsets of elemental concentrations are better than others for capturing the variability of elemental composition among agent samples. This is useful if it is desirable to reduce the number of elements that must be analyzed, or if one is comparing the merits of two different analytical methods that measure different sets of elements. A description of this procedure as applied to the bullet lead analysis problem is provided in reference 7.
The sample set that would be generated by the plan outlined in section 4 would also be useful for validating the use of other types of measurements for sample matching. For example, isotopic signatures could easily be evaluated by the same kind of approach, assuming a suitable metric analogous to Δ could be formulated. Approaches based on the morphology of samples may also be feasible if an objective metric could be formulated. Finally, the sample set outlined above could also contribute to the evaluation and validation of other SOPs e.g. analyses that aim to detect residual agar. 40. Whether agents or surrogates are grown in legitimate research labs only a small number of batches of limited size are produced. Similarly, except for state funded military programs, the illicit production of biological agents is expected to involve very limited quantities of material. 41. It is interesting to note that there is often a strong association between a particular laboratory and particular growth media, consistent with the observation that researchers 
Appendix 1. Source Attribution
Consider the case where a questioned sample is compared to an agent sample (the "source sample") found at a possible source lab, and a certain value of the test statistic Δ is  obtained. Given the possibility of a false match, what is the likelihood that the questioned sample came from the suspect lab? Let L 0 be the hypothesis that the questioned sample was made in the same lab as the source sample, and  L 0 the hypothesis that it was made elsewhere. The odds that the questioned sample comes from the suspect lab given that the elemental vectors of the questioned and source sample pair differ by Δ is given by: The fourth set {B 0  L 0 } is an empty set, since two samples made in different laboratories clearly cannot come from the same batch. It is important to note, that samples drawn from different batches can come from batches made by identical or different processes. In set notation:
Using the values given in the table, note that: Probability that the questioned sample was drawn from the same batch as the suspect source sample, given that they came from different labs 0 P( B 0 | L 0 )
Probability that the questioned sample was not drawn from the same batch as the suspect source sample, given that they came from different labs If the suspect lab made only a single batch of the material in question (M B = 1) then the probability of observing Δ given that the samples came from the same lab is clearly the same as observing Δ if the samples came from the same batch. In this case the likelihood ratio in equation (A2) simply becomes:
However, if the lab made many independent batches of material (i.e. M B >> 1), the likelihood ratio will primarily depend on the probability of observing Δ among different batches made in the same lab, and
Because batches made in one lab are liable to be replicate batches while batches made in different laboratories are liable to be non-replicate even when made by the sample process, we expect
for some range of Δ values. Thus it is still possible to have probative weight to a given value of Δ even if a lab made many batches of agent and some are not available for testing.
In summary, the probative value of a given value of Δ is bounded by two limits (A1.7) and (A1.8) representing the cases where we are certain the lab produced only one batch of the material in question, and where the lab may have produced many batches of material.
The The likelihood ratios in (A1.7) and (A1.8) can therefore be expressed as the derivative of the relevant ROC curve, e.g.
The analysis above implies that there are 2 separate ROC curves that need to be determined in order to estimate the likelihood ratios (A7) and (A8). One of the ROC curves, P(Δ ≤ Δ b |B 0 L 0 ) versus P(Δ ≤ Δ b | B 0 L 0 ), involve batches made in the same laboratory. A conservative point of view is that batches of material made at the same laboratory are more likely to be replicate batches, and to use only one process, so that these quantities are conservatively estimated from experiments on sets of replicate batches. The most conservative estimate of the marginal probability, P(Δ ≤ Δ b | B 0 L 0 ), is obtained by having all replicate cultures made in one laboratory by one person, using the same lot of medium components or a pre-manufactured batch of growth medium, and carefully implemented quality control steps.
The other required ROC curve is P(Δ ≤ Δ b | B 0 L 0 ) versus P(Δ ≤ Δ b | B 0  L 0 ), which deals with samples made in different laboratories. The latter quantity is conservatively estimated from measurements on non-replicate batches of material made independently, but by the same process. Note that the joint hypothesis B 0 L 0 is equivalent to B 0 alone since the same batch of material must be made in the same laboratory. However, as noted above there is a distinction between multiple batches made at the same laboratory and batches made at different laboratories, i.e. between  B 0 L 0 and  B 0  L 0 . In section 4 of this report we follow the prescription suggested in this appendix that  B 0 L 0 is conservatively represented by replicate batches, while  B 0  L 0 is conservatively represented by non-replicate batches, whether or not they are actually made in different laboratories.
In general, the finding that two samples were made by the same process (P 0 ) has far less probative value in associating the questioned sample with a given laboratory, unless the process can be uniquely associated with that laboratory. Expanding the likelihood ratio for a match in terms of P 0 rather than B 0 , the analogues to equations (A1.3) and (A1.4) become:
P(Δ|L 0 ) = P(Δ|P 0 L 0 )•P(P 0 |L 0 ) + P(Δ| P 0 L 0 )•P( P 0 |L 0 ) (A1. 14) and P(Δ| L 0 ) = P(Δ|P 0  L 0 )•P(P 0 | L 0 ) + P(Δ| P 0  L 0 )•P( P 0 | L 0 ) (A1.15) P(P 0 |L 0 ) is the probability that two samples were made by the same process if they were made in the same laboratory. If other evidence made it highly likely that the suspect lab used only a single process to make bioagent material (i.e. P(P 0 |L 0 ) ≈ 1) then the probability of observing Δ given that the samples came from the same lab is clearly the same as observing Δ if the samples were made by the same process (i.e. P(Δ|L 0 ) ≈ P(Δ|P 0 L 0 ). Similarly, if it is highly unlikely that a different laboratory might use the same In the more general case where it is possible that different processes may have been carried out in the same laboratory, the likelihood ratio is more difficult to calculate exactly, but it may be possible to argue that a process matching test still has probative value (i.e. LR(Δ) >1). This will be true if the P(Δ| P 0 L 0 ) and P(Δ| P 0  L 0 ) are sufficiently small compared to P(Δ|P 0 L 0 ) and P(Δ|P 0  L 0 ) and we accept the proposition that P(P 0 |L 0 ) > P(P 0 | L 0 ). Probability that the two samples will have the observed Δ value given that the samples were made by the same process in the same laboratory P(Δ|P 0  L 0 )
Probability that the two samples will have the observed Δ value given that the samples were made by the same process in different laboratories P(Δ| P 0 L 0 ) Probability that the two samples will have the observed Δ value given that the samples were made by different processes in the same laboratory P(Δ| P 0  L 0 )
Probability that the two samples will have the observed Δ value given that the samples were made by different processes in different laboratories P(P 0 |L 0 ) Probability that two samples were made by the same process, given that they were made in the same laboratory P( P 0 |L 0 ) Probability that two samples were made by different processes, given that they were made in the same laboratory P(P 0 | L 0 ) Probability that two samples were made by the same process, given that they were made in different laboratories P( P 0 | L 0 ) Probability that two samples were made by different processes, given that they were made in different laboratories Another case where the likelihood ratio takes a simpler form is where there is essentially only one process that can be used to make the bioagent. Such a situation may exist for certain fastidious bacterial agents. In this case, April 21, 2006 Page 37 of 41 P(P 0 |L 0 ) ≈ P(P 0 | L 0 ) ≈ 1 (A1. 19) And the likelihood ratio reduces to :
Since we expect that the probability of finding a match between two samples made by a given process in the same lab is higher than the probability of a match between samples made in different labs, even when made by the same process, the likelihood ratio will be greater than 1 and a process match will have some probative value towards attribution.
To summarize this discussion, the relevant conditional probabilities associated with process matching are given in Table A1 .2. Page 38 of 41
Appendix 2. Subpopulation size in the 3x3 partial factorial design
In section 4 the sample set is generated by drawing 3 replicate samples from each of the 18 separate batches, leading to 54 individual samples for analysis. This leads to 1431 possible pairwise comparisons of the elemental vectors. (If there are n samples then the number of pairwise comparisons is 1/2n(n-1).) This set of pairwise sample comparisons can be broken down into sets of pairs drawn from the various categories described in appendix 1: e.g. pairs drawn from the same batch (B 0 L 0 ), from different batches produced in different labs using the same process ( L 0 P 0 ), etc.
First consider pairwise comparisons of samples produced in the same laboratory. Table  A2 .1 represents the matrix of pairwise comparisons of samples produced by 3 different processes at a given laboratory. For each process, we can consider the comparison of samples made by the same process in different laboratories. These are given in Table A2 .2.
Each of the 11 cells represent 9 unique pairwise comparisons, so for the 3 processes we have 9 x 11 x 3 = 297 pairs in the set { L 0 P 0 }. For each pair of processes, we can construct the matrix describing the pairs of samples comparing different processes at different laboratories. This is shown in Table A2 .3 for processes 1 and 3. There are 25 cells in this matrix, each representing 9 unique pairwise comparisons. Since there are 3 unique pairs of processes, the total number of comparisons in the set { P 0  L 0 } is 25 x 9 x 3 = 675.  P 0  L 0  P 0  L 0  P 0  L 0  P 0  L 0  P 0  L 0 Table A2 .4 summarizes the numbers of members in the various sub-populations for the process-laboratory comparisons. Thus, for example, the probability of drawing at random a pair of samples representing the same process carried out at the same laboratory from this set is 162/1431 or 11%.
For each process, we can summarize the various comparisons among batches as in Table  A2 .5. The structure of this matrix is the same as that of A2. shaded cells represent comparisons among samples from different batches made by the same process at the same lab { B 0 P 0 L 0 }. By analogy with table A2.1 there are 108 pairs in this set. Finally the yellow shaded cells in Table A2 .5 represent a total of 297 pairwise comparisons between samples drawn from different batches made by the same process at different laboratories { L 0 P 0  B 0 }. The numbers of members in each of the sets defined by Note that the following relationships hold: Clearly, the probability of randomly drawing two samples from the same batch from the entire set of samples is 54/1431 or 3.8%. The probability of drawing a pair of samples that were made in the same lab, but not in the same batch is given by (108 + 297)/1431 and the probability of drawing a pair of samples that were grown in different laboratories is 972/1431. When determining the marginal probabilities P(Δ ≤ Δ b | B 0 L 0 ) and P(Δ ≤ Δ b | B 0  L 0 ) in order to generate ROC curves, it is important to remember that batches from different processes are included in the sample sets { B 0 L 0 } and { B 0  L 0 }, as indicated in (A2.8) and (A2.9).
